Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04985630 · ClinicalTrials.gov registry record · NA

The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots

A NA study of Healthy and Healthy Aging, sponsored by Amazentis.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
1
Study location

NCT04985630: Recruiting NA study of Healthy and Healthy Aging, sponsored by Amazentis.

NCT04985630 is a NA study of Healthy and Healthy Aging that is actively recruiting participants, run by Amazentis. The registered enrollment target is 250 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04985630, a NA study of Healthy and Healthy Aging, is actively recruiting participants, sponsored by Amazentis.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
1
Study location

Study Summary

Open labelled, virtual home based study to assess the test repeatability and the failure/rejection rate of the samples collected at home by participants.

Primary Outcome

Acceptability target goal is to hit 80% of analyzed samples

Interventions

  • DIETARY_SUPPLEMENT Mitopure
  • DIETARY_SUPPLEMENT Pomegranate Juice

Study Locations (1)

California

  • Amazentis USA - San Francisco

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2021-08-30
Est. Completion 2026-08-31
Phase NA
Amazentis

5 total trials

What NCT04985630 shows while recruiting

NCT04985630 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (61% lower).

The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Mitopure is the first listed.

NCT04985630 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04985630 about?

NCT04985630 is a clinical study titled "The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots". Open labelled, virtual home based study to assess the test repeatability and the failure/rejection rate of the samples collected at home by participants.

What is the current status of trial NCT04985630?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2021-08-30. Estimated completion is 2026-08-31.

What conditions does trial NCT04985630 study?

This clinical trial studies the following conditions: Healthy, Healthy Aging, Healthy Diet.

What interventions are being tested in trial NCT04985630?

The interventions under investigation include: Mitopure (DIETARY_SUPPLEMENT), Pomegranate Juice (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04985630?

This trial is sponsored by Amazentis, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04985630 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04985630's enrollment target sits among peer trials

250 99th of 1090 higher than 990 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04985630, the US trial registry maintained by the National Library of Medicine. NCT04985630 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.